See every side of every news story
Published loading...Updated

Insulet sales increase 22% in 2025, Q4 performance beats Street

Summary by Drug Delivery Business
Insulet (Nasdaq:PODD) shares dipped after hours today on fourth-quarter results that came in ahead of the consensus forecast. Shares of PODD fell 2.7% to $280.66 apiece in post-market trading today. The Acton, Massachusetts-based automated insulin delivery technology maker reported profits of $100.7 million. That equals $1.39 per share on sales of $597.5 million for the three months ended Dec. 31, 2024. Insulet recorded a 2.5% bottom-line slide …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Drug Delivery Business broke the news in on Thursday, February 20, 2025.
Sources are mostly out of (0)